Cellebrite Di Ltd (CLBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,781 | -1,876 | N/A | N/A | N/A |
| Depreciation Amortization | 5,879 | 4,079 | N/A | N/A | N/A |
| Income taxes - deferred | -2,818 | -1,667 | N/A | N/A | N/A |
| Accounts receivable | -19,731 | -12,220 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 22,449 | -158 | N/A | N/A | N/A |
| Other Working Capital | 49,708 | 2,838 | N/A | N/A | N/A |
| Other Operating Activity | 5,242 | 25,137 | 0 | 0 | 0 |
| Operating Cash Flow | $66,510 | $16,133 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,181 | -6,209 | N/A | N/A | N/A |
| Net Acquisitions | -15,046 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | 14,778 | -40,513 | N/A | N/A | N/A |
| Investing Cash Flow | $-6,449 | $-46,722 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,492 | 141 | N/A | N/A | N/A |
| Common Stock Repurchased | -85 | -808 | N/A | N/A | N/A |
| Dividend Paid | -10,000 | -25,000 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 101,205 | 0 | 0 | 0 |
| Financing Cash Flow | $-8,593 | $75,538 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 695 | -67 | N/A | N/A | N/A |
| Beginning Cash Position | 81,683 | 36,801 | N/A | N/A | N/A |
| End Cash Position | 133,846 | 81,683 | N/A | N/A | N/A |
| Net Cash Flow | $52,163 | $44,882 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 66,510 | 16,133 | N/A | N/A | N/A |
| Capital Expenditure | -6,181 | -6,209 | N/A | N/A | N/A |
| Free Cash Flow | 60,329 | 9,924 | 0 | 0 | 0 |